• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Digipath Announces Record Fiscal Year Results for 2017

January 2, 2018

 

LAS VEGAS, Jan. 2, 2018 /PRNewswire/ -- Digipath, Inc. (OTC:DIGP) ("DIGP" or the "Company"), a service oriented independent testing laboratory and media firm focused on the developing cannabis market, today announced financial and operating results for the fiscal year ended September 30, 2017.

 

2017 Company Highlights

 

 

  • Ended fiscal year debt free with $380,189 of working capital, including $178,177 of cash on hand

  • Annual sales were $1,898,172, an increase of 132% on a year-over-year basis

  • Fourth quarter sales of $602,057 increased by 74% over the third quarter, and by 93% vs. the fourth quarter of 2016, as Nevada recreational cannabis sales commenced in July 2017, resulting in another record quarter

  • Reduced our net loss by 71% over the comparative net loss in 2016

  • Adjusted EBITDA for the year was $(375,377), compared to Adjusted EBITDA of $(949,946) for the previous fiscal year, an improvement of approximately 60% on a year-over-year basis

 

 

The table below shows the preliminary results and key metrics:

 

Management Comment

 

Todd Denkin, Digipath's President & COO, commented, "We are extremely pleased with our results for fiscal 2017 and look forward to a full year of testing for both medical and recreational cannabis products in 2018. It is also rewarding to see our progress reflected in our recent stock price. Over $126 million of cannabis-related products have been sold in Nevada since adult use went into effect on July 1, 2017. People don't realize that Nevada had more sales than Coloradoexperienced in their first four months of adult-use cannabis. We anticipate a continued significant increase in demand for cannabis lab testing services in 2018. In addition, with recreational cannabis now legal in California, we continue to work with our previously announced joint venture partner to launch an independent testing lab in California during 2018 as we seek to replicate our successful Nevada operations in other legal jurisdictions."

 

Adjusted EBITDA

 

We define Adjusted EBITDA as net earnings (loss) before (i) other income (expense), (ii) interest income, (iii) interest expense, (iv) bad debts, (v) depreciation and amortization, (vi) impairment of securities available-for-sale costs, (vii) non-cash expenses relating to share based payments recognized under ASC Topic 718, (viii) gain on early extinguishment of debt, and (ix) equity in losses of unconsolidated entity. We believe the use of this non-GAAP financial measure provides useful information to investors regarding our current financial performance; however, Adjusted EBITDA does not represent, and should not be considered an alternative to GAAP measurements. Specifically, we believe Adjusted EBITDA results provide useful information to both management and investors by excluding certain income and expenses that our management believes are not indicative of our core operating results, we believe that non-GAAP financial measures have limitations and do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP and that Adjusted EBITDA should only be used to evaluate our results of operations in conjunction with the corresponding GAAP financial measures. A reconciliation of Adjusted EBITDA to net loss is included below:

 

 

 

 

 

 

 

 

 

About Digipath, Inc. (OTC:DIGP)

 

Digipath, Inc., supports the cannabis industry's best practices for reliable testing, cannabis education and training, and brings unbiased cannabis news coverage to the cannabis industry.

 

Digipath Labs provides pharmaceutical-grade analysis and testing to the cannabis industry to ensure producers, consumers and patients know exactly what is in the cannabis they ingest and to help maximize the quality of its client's products through analysis, research, development, and standardization.

 

Information about Forward-Looking Statements

 

This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting Digipath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Read more articles tagged:

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.